Read + Share
Amedeo Smart
Independent Medical Education
Scheffges C, Devy J, Giustiniani J, Francois S, et al. Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications. Breast Cancer Res 2024;26:28.PMID: 38360636
Email
LinkedIn
Facebook
Twitter
Privacy Policy